ArticleCrohn's & colitis 3602026

Effectiveness and safety of adalimumab biosimilar in bio-naive patients with inflammatory bowel disease: a real-life multicenter observational study comparing ABP501, SB5, MSB11022, GP2017, and FKB327.

Cristina Regueiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.